Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Ketamine | 16 | 2022 | 527 | 3.750 |
Why?
|
Depressive Disorder, Major | 46 | 2024 | 4810 | 2.370 |
Why?
|
Antidepressive Agents | 24 | 2022 | 2903 | 1.660 |
Why?
|
Suicidal Ideation | 3 | 2020 | 1467 | 0.880 |
Why?
|
Placebo Effect | 1 | 2024 | 515 | 0.700 |
Why?
|
Riluzole | 1 | 2019 | 62 | 0.640 |
Why?
|
Excitatory Amino Acid Antagonists | 3 | 2020 | 451 | 0.620 |
Why?
|
Depression | 13 | 2024 | 8225 | 0.590 |
Why?
|
Bipolar Disorder | 24 | 2023 | 5130 | 0.560 |
Why?
|
Infusions, Intravenous | 7 | 2022 | 2228 | 0.550 |
Why?
|
Tryptophan Hydroxylase | 8 | 2004 | 93 | 0.480 |
Why?
|
Polymorphism, Genetic | 19 | 2005 | 4249 | 0.480 |
Why?
|
Double-Blind Method | 22 | 2024 | 12430 | 0.440 |
Why?
|
Monoamine Oxidase | 3 | 2002 | 179 | 0.430 |
Why?
|
Receptors, Dopamine D2 | 9 | 2004 | 471 | 0.430 |
Why?
|
Depressive Disorder | 13 | 2019 | 3715 | 0.410 |
Why?
|
Benzothiazoles | 1 | 2013 | 244 | 0.400 |
Why?
|
Suicide, Attempted | 2 | 2020 | 1413 | 0.400 |
Why?
|
Mood Disorders | 10 | 2005 | 1127 | 0.380 |
Why?
|
Antidepressive Agents, Second-Generation | 6 | 2006 | 490 | 0.380 |
Why?
|
Electroconvulsive Therapy | 2 | 2016 | 505 | 0.380 |
Why?
|
Membrane Transport Proteins | 9 | 2004 | 1029 | 0.360 |
Why?
|
Yoga | 2 | 2024 | 277 | 0.350 |
Why?
|
Pregnanolone | 2 | 2020 | 67 | 0.330 |
Why?
|
Fluoxetine | 3 | 2007 | 732 | 0.310 |
Why?
|
Psychiatric Status Rating Scales | 15 | 2018 | 6020 | 0.300 |
Why?
|
Sertraline | 2 | 2020 | 210 | 0.280 |
Why?
|
Fluvoxamine | 7 | 2005 | 77 | 0.280 |
Why?
|
Citalopram | 3 | 2019 | 402 | 0.270 |
Why?
|
Dopamine | 3 | 2024 | 1581 | 0.270 |
Why?
|
Receptor, Serotonin, 5-HT2A | 4 | 2004 | 64 | 0.270 |
Why?
|
Receptors, Serotonin | 3 | 2002 | 210 | 0.270 |
Why?
|
Treatment Outcome | 32 | 2024 | 65286 | 0.270 |
Why?
|
Drug Administration Schedule | 4 | 2019 | 4853 | 0.260 |
Why?
|
Psychotic Disorders | 7 | 2015 | 3275 | 0.260 |
Why?
|
Middle Aged | 67 | 2024 | 223267 | 0.260 |
Why?
|
Huntington Disease | 1 | 2013 | 1147 | 0.260 |
Why?
|
Membrane Glycoproteins | 9 | 2004 | 3702 | 0.250 |
Why?
|
Adult | 64 | 2024 | 223305 | 0.250 |
Why?
|
Nerve Tissue Proteins | 10 | 2004 | 4401 | 0.230 |
Why?
|
Dose-Response Relationship, Drug | 7 | 2020 | 10745 | 0.230 |
Why?
|
Catechol O-Methyltransferase | 3 | 2004 | 250 | 0.230 |
Why?
|
Drug Synergism | 4 | 2017 | 1757 | 0.230 |
Why?
|
Remission Induction | 3 | 2016 | 2413 | 0.220 |
Why?
|
Deep Brain Stimulation | 3 | 2016 | 850 | 0.200 |
Why?
|
Outpatients | 3 | 2020 | 1596 | 0.200 |
Why?
|
Lithium | 2 | 2002 | 599 | 0.200 |
Why?
|
Female | 73 | 2024 | 396532 | 0.200 |
Why?
|
Male | 68 | 2024 | 364154 | 0.190 |
Why?
|
Humans | 95 | 2024 | 766812 | 0.190 |
Why?
|
Serotonin Plasma Membrane Transport Proteins | 10 | 2006 | 326 | 0.180 |
Why?
|
Carrier Proteins | 7 | 2002 | 4926 | 0.180 |
Why?
|
Maintenance | 1 | 2020 | 25 | 0.180 |
Why?
|
Paroxetine | 5 | 2005 | 181 | 0.160 |
Why?
|
Time Factors | 5 | 2021 | 40149 | 0.160 |
Why?
|
Follicular Phase | 1 | 2019 | 143 | 0.160 |
Why?
|
Luteal Phase | 1 | 2019 | 138 | 0.160 |
Why?
|
Delusions | 9 | 2002 | 300 | 0.160 |
Why?
|
Tyrosine 3-Monooxygenase | 4 | 2003 | 367 | 0.160 |
Why?
|
S-Adenosylmethionine | 1 | 2019 | 219 | 0.150 |
Why?
|
Administration, Intranasal | 1 | 2020 | 482 | 0.150 |
Why?
|
Psychotropic Drugs | 1 | 2023 | 880 | 0.150 |
Why?
|
Positron-Emission Tomography | 3 | 2024 | 6548 | 0.150 |
Why?
|
Magnetic Field Therapy | 1 | 2017 | 27 | 0.140 |
Why?
|
Irritable Mood | 2 | 2020 | 196 | 0.140 |
Why?
|
Diagnostic and Statistical Manual of Mental Disorders | 3 | 2013 | 1988 | 0.140 |
Why?
|
Neuromuscular Depolarizing Agents | 1 | 2016 | 44 | 0.130 |
Why?
|
Androstanols | 1 | 2016 | 47 | 0.130 |
Why?
|
Drug Therapy, Combination | 7 | 2020 | 6306 | 0.130 |
Why?
|
Succinylcholine | 1 | 2016 | 67 | 0.130 |
Why?
|
Seasons | 1 | 2002 | 1519 | 0.130 |
Why?
|
Pindolol | 4 | 2005 | 34 | 0.130 |
Why?
|
Neuromuscular Nondepolarizing Agents | 1 | 2016 | 145 | 0.130 |
Why?
|
Progesterone | 1 | 2019 | 752 | 0.120 |
Why?
|
Young Adult | 17 | 2022 | 59939 | 0.120 |
Why?
|
Hypericum | 1 | 2014 | 58 | 0.120 |
Why?
|
Placebos | 2 | 2012 | 1659 | 0.120 |
Why?
|
Premenopause | 1 | 2019 | 1039 | 0.120 |
Why?
|
Postmenopause | 3 | 2020 | 2517 | 0.110 |
Why?
|
Receptors, Dopamine D4 | 7 | 2004 | 168 | 0.110 |
Why?
|
Synaptic Transmission | 1 | 2020 | 1175 | 0.110 |
Why?
|
Naltrexone | 1 | 2016 | 319 | 0.110 |
Why?
|
Internal Capsule | 1 | 2014 | 137 | 0.110 |
Why?
|
Fatty Acids, Omega-3 | 1 | 2022 | 1399 | 0.100 |
Why?
|
Diet, Mediterranean | 1 | 2019 | 746 | 0.100 |
Why?
|
Exercise Therapy | 1 | 2019 | 935 | 0.100 |
Why?
|
Sex Characteristics | 2 | 2019 | 2645 | 0.100 |
Why?
|
Menopause | 1 | 2019 | 1656 | 0.090 |
Why?
|
Anger | 2 | 2020 | 402 | 0.090 |
Why?
|
Plant Extracts | 1 | 2014 | 496 | 0.090 |
Why?
|
Injections, Intramuscular | 1 | 2012 | 551 | 0.090 |
Why?
|
Genotype | 15 | 2007 | 13036 | 0.090 |
Why?
|
Pilot Projects | 6 | 2022 | 8728 | 0.090 |
Why?
|
Cerebral Cortex | 2 | 2018 | 5753 | 0.090 |
Why?
|
Dopamine Agonists | 1 | 2013 | 346 | 0.090 |
Why?
|
Institutionalization | 1 | 1991 | 108 | 0.090 |
Why?
|
Radiopharmaceuticals | 1 | 2020 | 2703 | 0.090 |
Why?
|
Thiazoles | 1 | 2018 | 1529 | 0.090 |
Why?
|
Paranoid Disorders | 2 | 1999 | 61 | 0.080 |
Why?
|
Testosterone | 1 | 2020 | 2495 | 0.080 |
Why?
|
Electric Stimulation Therapy | 1 | 2015 | 635 | 0.080 |
Why?
|
Disease Management | 1 | 2020 | 2533 | 0.080 |
Why?
|
Midazolam | 2 | 2022 | 267 | 0.080 |
Why?
|
Pattern Recognition, Automated | 1 | 2015 | 980 | 0.080 |
Why?
|
Antimanic Agents | 2 | 2023 | 523 | 0.080 |
Why?
|
Reaction Time | 1 | 2015 | 2085 | 0.080 |
Why?
|
Combined Modality Therapy | 2 | 2017 | 8540 | 0.080 |
Why?
|
Piperazines | 2 | 2018 | 2547 | 0.080 |
Why?
|
Aged | 22 | 2020 | 171344 | 0.070 |
Why?
|
Universities | 1 | 2013 | 1004 | 0.070 |
Why?
|
Long-Term Care | 1 | 2012 | 630 | 0.070 |
Why?
|
Central Nervous System Stimulants | 1 | 2016 | 1168 | 0.070 |
Why?
|
Genetic Variation | 6 | 2006 | 6613 | 0.070 |
Why?
|
Anxiety Disorders | 1 | 2018 | 2743 | 0.070 |
Why?
|
Massachusetts | 1 | 2020 | 8890 | 0.070 |
Why?
|
Dementia | 1 | 2022 | 2741 | 0.070 |
Why?
|
Drug Monitoring | 1 | 2013 | 962 | 0.070 |
Why?
|
Receptors, Dopamine D3 | 3 | 2022 | 106 | 0.070 |
Why?
|
Obsessive-Compulsive Disorder | 1 | 2016 | 1495 | 0.070 |
Why?
|
Psychometrics | 1 | 2016 | 3060 | 0.070 |
Why?
|
Retrospective Studies | 8 | 2020 | 81657 | 0.070 |
Why?
|
Magnetic Resonance Imaging | 4 | 2024 | 36570 | 0.070 |
Why?
|
Heterotrimeric GTP-Binding Proteins | 2 | 2004 | 94 | 0.070 |
Why?
|
Executive Function | 1 | 2015 | 1396 | 0.070 |
Why?
|
Cerebrovascular Circulation | 1 | 2016 | 2671 | 0.060 |
Why?
|
Recurrence | 4 | 2019 | 8507 | 0.060 |
Why?
|
Minisatellite Repeats | 1 | 2005 | 162 | 0.060 |
Why?
|
Anxiety | 2 | 2018 | 4668 | 0.060 |
Why?
|
Cyclic AMP Response Element-Binding Protein | 1 | 2007 | 501 | 0.060 |
Why?
|
Receptors, GABA-A | 2 | 1999 | 624 | 0.060 |
Why?
|
Controlled Clinical Trials as Topic | 1 | 2005 | 187 | 0.060 |
Why?
|
Regulatory Sequences, Nucleic Acid | 3 | 2004 | 792 | 0.060 |
Why?
|
Registries | 1 | 2020 | 8352 | 0.060 |
Why?
|
Alleles | 11 | 2006 | 6896 | 0.060 |
Why?
|
Drug Therapy | 1 | 2007 | 504 | 0.050 |
Why?
|
Gene Frequency | 7 | 2005 | 3624 | 0.050 |
Why?
|
Students | 1 | 2013 | 1741 | 0.050 |
Why?
|
Adolescent | 11 | 2020 | 88902 | 0.050 |
Why?
|
Cross-Over Studies | 2 | 2022 | 2105 | 0.050 |
Why?
|
Dopamine Plasma Membrane Transport Proteins | 1 | 2005 | 410 | 0.050 |
Why?
|
Euphoria | 1 | 2022 | 64 | 0.050 |
Why?
|
Serotonin Antagonists | 2 | 2018 | 146 | 0.050 |
Why?
|
Raclopride | 1 | 2022 | 98 | 0.050 |
Why?
|
Follow-Up Studies | 3 | 2016 | 39312 | 0.050 |
Why?
|
Body Mass Index | 1 | 2020 | 13050 | 0.050 |
Why?
|
Psychopathology | 2 | 2021 | 434 | 0.050 |
Why?
|
Italy | 5 | 2003 | 856 | 0.050 |
Why?
|
Schizophrenia | 5 | 2002 | 6976 | 0.050 |
Why?
|
Activities of Daily Living | 1 | 1991 | 2429 | 0.050 |
Why?
|
Prefrontal Cortex | 2 | 2022 | 2224 | 0.050 |
Why?
|
Linkage Disequilibrium | 3 | 2005 | 1996 | 0.050 |
Why?
|
Software | 1 | 2015 | 4464 | 0.050 |
Why?
|
Systems Analysis | 1 | 2021 | 168 | 0.050 |
Why?
|
Attitude of Health Personnel | 1 | 2014 | 3927 | 0.040 |
Why?
|
Gene Expression | 3 | 2001 | 7585 | 0.040 |
Why?
|
GABA Modulators | 1 | 2020 | 108 | 0.040 |
Why?
|
Protein Subunits | 1 | 2003 | 940 | 0.040 |
Why?
|
Haplotypes | 1 | 2005 | 2726 | 0.040 |
Why?
|
Bupropion | 1 | 2020 | 303 | 0.040 |
Why?
|
Eicosapentaenoic Acid | 1 | 2022 | 565 | 0.040 |
Why?
|
Serotonin | 2 | 2001 | 1045 | 0.040 |
Why?
|
Affective Disorders, Psychotic | 1 | 1999 | 187 | 0.040 |
Why?
|
Image Processing, Computer-Assisted | 1 | 2015 | 8928 | 0.040 |
Why?
|
Polymerase Chain Reaction | 6 | 2006 | 6066 | 0.040 |
Why?
|
Health Status | 1 | 1991 | 4087 | 0.040 |
Why?
|
Sleep Initiation and Maintenance Disorders | 2 | 2005 | 1104 | 0.040 |
Why?
|
Patient Discharge | 1 | 1991 | 3466 | 0.040 |
Why?
|
Cognition | 1 | 2015 | 7057 | 0.040 |
Why?
|
Disease Progression | 2 | 2007 | 13642 | 0.030 |
Why?
|
Chromosomes, Human, Pair 11 | 1 | 1998 | 412 | 0.030 |
Why?
|
Physicians | 1 | 2014 | 4591 | 0.030 |
Why?
|
Antipsychotic Agents | 2 | 2023 | 3078 | 0.030 |
Why?
|
Benzodiazepines | 1 | 2022 | 1137 | 0.030 |
Why?
|
Mental Health | 1 | 1991 | 3269 | 0.030 |
Why?
|
Age of Onset | 5 | 2002 | 3343 | 0.030 |
Why?
|
Adrenergic beta-Antagonists | 1 | 2002 | 1241 | 0.030 |
Why?
|
Randomized Controlled Trials as Topic | 3 | 2018 | 10384 | 0.030 |
Why?
|
Trans-Activators | 1 | 2005 | 2856 | 0.030 |
Why?
|
Docosahexaenoic Acids | 1 | 2022 | 915 | 0.030 |
Why?
|
Leukocytes, Mononuclear | 1 | 2022 | 1852 | 0.030 |
Why?
|
Severity of Illness Index | 6 | 2007 | 15912 | 0.030 |
Why?
|
Random Allocation | 1 | 2019 | 2394 | 0.030 |
Why?
|
Genetic Linkage | 1 | 2000 | 2342 | 0.030 |
Why?
|
Regression Analysis | 2 | 2000 | 6329 | 0.030 |
Why?
|
Gyrus Cinguli | 1 | 2020 | 1118 | 0.030 |
Why?
|
Predictive Value of Tests | 3 | 2015 | 15425 | 0.030 |
Why?
|
Anticonvulsants | 1 | 2023 | 1921 | 0.030 |
Why?
|
Brain | 1 | 2020 | 27158 | 0.030 |
Why?
|
Erythrocytes | 1 | 2002 | 2412 | 0.030 |
Why?
|
Analysis of Variance | 4 | 2004 | 6214 | 0.030 |
Why?
|
Single-Blind Method | 1 | 2016 | 1587 | 0.030 |
Why?
|
Schizophrenic Psychology | 1 | 1999 | 1647 | 0.030 |
Why?
|
Chi-Square Distribution | 3 | 2004 | 3431 | 0.030 |
Why?
|
Interleukin-6 | 1 | 2022 | 3226 | 0.020 |
Why?
|
Transcranial Magnetic Stimulation | 1 | 2022 | 1498 | 0.020 |
Why?
|
Hydrocortisone | 1 | 2020 | 1838 | 0.020 |
Why?
|
Personality Inventory | 2 | 2007 | 1019 | 0.020 |
Why?
|
Muscle Contraction | 1 | 2016 | 1208 | 0.020 |
Why?
|
Clinical Trials as Topic | 1 | 2007 | 8045 | 0.020 |
Why?
|
Models, Psychological | 1 | 2015 | 823 | 0.020 |
Why?
|
C-Reactive Protein | 1 | 2022 | 3853 | 0.020 |
Why?
|
Psychological Tests | 2 | 2003 | 642 | 0.020 |
Why?
|
Organ Size | 1 | 2015 | 2262 | 0.020 |
Why?
|
Attention Deficit Disorder with Hyperactivity | 1 | 2005 | 3724 | 0.020 |
Why?
|
Anti-Inflammatory Agents | 1 | 2019 | 1805 | 0.020 |
Why?
|
Prevalence | 1 | 2007 | 15835 | 0.020 |
Why?
|
Caregivers | 1 | 2022 | 2303 | 0.020 |
Why?
|
Dietary Supplements | 1 | 2022 | 3429 | 0.020 |
Why?
|
Overweight | 1 | 2020 | 2447 | 0.020 |
Why?
|
Polymorphism, Single Nucleotide | 1 | 2007 | 16044 | 0.020 |
Why?
|
DNA | 4 | 2004 | 7210 | 0.020 |
Why?
|
Computer Simulation | 1 | 2020 | 6258 | 0.020 |
Why?
|
Incidence | 2 | 2020 | 21527 | 0.020 |
Why?
|
DNA Primers | 2 | 2001 | 2826 | 0.020 |
Why?
|
Membrane Proteins | 1 | 2003 | 7869 | 0.020 |
Why?
|
Prognosis | 1 | 2007 | 29959 | 0.020 |
Why?
|
CLOCK Proteins | 1 | 2005 | 87 | 0.020 |
Why?
|
Wolfram Syndrome | 1 | 2003 | 14 | 0.010 |
Why?
|
Cross-Sectional Studies | 2 | 2016 | 26309 | 0.010 |
Why?
|
Jews | 1 | 2005 | 359 | 0.010 |
Why?
|
Nursing Homes | 1 | 1991 | 1084 | 0.010 |
Why?
|
Case-Control Studies | 2 | 2015 | 22248 | 0.010 |
Why?
|
Inflammation | 1 | 2022 | 10863 | 0.010 |
Why?
|
Chromosomes, Human, Pair 22 | 1 | 2003 | 348 | 0.010 |
Why?
|
Self Report | 1 | 2013 | 3771 | 0.010 |
Why?
|
Neuropsychological Tests | 1 | 2015 | 7119 | 0.010 |
Why?
|
Aged, 80 and over | 3 | 2016 | 59548 | 0.010 |
Why?
|
Gene Expression Regulation | 1 | 1999 | 11924 | 0.010 |
Why?
|
DNA Mutational Analysis | 2 | 2001 | 4114 | 0.010 |
Why?
|
Schizophrenia, Paranoid | 1 | 2001 | 102 | 0.010 |
Why?
|
Social Support | 1 | 1991 | 2191 | 0.010 |
Why?
|
Serotonin Receptor Agonists | 1 | 2001 | 151 | 0.010 |
Why?
|
Individuality | 1 | 2001 | 303 | 0.010 |
Why?
|
Chronic Disease | 1 | 2014 | 9358 | 0.010 |
Why?
|
Prospective Studies | 2 | 2016 | 54872 | 0.010 |
Why?
|
Life Style | 1 | 1991 | 3926 | 0.010 |
Why?
|
Anomie | 1 | 1998 | 9 | 0.010 |
Why?
|
Inpatients | 2 | 2002 | 2566 | 0.010 |
Why?
|
Obesity | 1 | 2020 | 13090 | 0.010 |
Why?
|
Chromosomes, Human, Pair 17 | 1 | 1999 | 418 | 0.010 |
Why?
|
Pedigree | 1 | 2005 | 4539 | 0.010 |
Why?
|
Risk Factors | 2 | 2002 | 74889 | 0.010 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 1 | 2004 | 4570 | 0.010 |
Why?
|
Length of Stay | 1 | 1991 | 6491 | 0.010 |
Why?
|
Reproducibility of Results | 1 | 2015 | 20146 | 0.010 |
Why?
|
Factor Analysis, Statistical | 1 | 1999 | 1001 | 0.010 |
Why?
|
Hallucinations | 1 | 1999 | 373 | 0.010 |
Why?
|
Point Mutation | 1 | 2001 | 1592 | 0.010 |
Why?
|
Genetic Predisposition to Disease | 3 | 2005 | 18076 | 0.010 |
Why?
|
Exons | 1 | 2001 | 2392 | 0.010 |
Why?
|
Statistics as Topic | 1 | 2002 | 2350 | 0.010 |
Why?
|
Ambulatory Care | 1 | 2007 | 2779 | 0.010 |
Why?
|
Psychomotor Agitation | 1 | 1998 | 307 | 0.010 |
Why?
|
Promoter Regions, Genetic | 1 | 2006 | 5795 | 0.010 |
Why?
|
Personality Disorders | 1 | 1999 | 727 | 0.010 |
Why?
|
Somatoform Disorders | 1 | 1998 | 425 | 0.010 |
Why?
|
Genetic Markers | 1 | 2000 | 2603 | 0.010 |
Why?
|
Europe | 1 | 2000 | 3430 | 0.010 |
Why?
|
Sex Factors | 1 | 2007 | 10619 | 0.010 |
Why?
|
Family | 1 | 2003 | 3209 | 0.010 |
Why?
|
United States | 1 | 2020 | 72945 | 0.010 |
Why?
|
Multivariate Analysis | 1 | 2005 | 12064 | 0.010 |
Why?
|
Phenotype | 2 | 2000 | 16722 | 0.010 |
Why?
|
Suicide | 1 | 2002 | 1606 | 0.010 |
Why?
|
gamma-Aminobutyric Acid | 1 | 1998 | 1139 | 0.010 |
Why?
|
Chromosome Mapping | 1 | 1999 | 4618 | 0.010 |
Why?
|
Cluster Analysis | 1 | 1998 | 2721 | 0.010 |
Why?
|
RNA, Messenger | 1 | 2004 | 12795 | 0.010 |
Why?
|
Base Sequence | 1 | 2000 | 12415 | 0.000 |
Why?
|
Patient Readmission | 1 | 2002 | 3283 | 0.000 |
Why?
|
Sequence Analysis, DNA | 1 | 1999 | 4780 | 0.000 |
Why?
|
Motor Activity | 1 | 1998 | 2711 | 0.000 |
Why?
|
Age Factors | 1 | 2003 | 18397 | 0.000 |
Why?
|
Comorbidity | 1 | 1999 | 10580 | 0.000 |
Why?
|
Child, Preschool | 1 | 2005 | 42577 | 0.000 |
Why?
|
Child | 1 | 2005 | 80670 | 0.000 |
Why?
|
Cohort Studies | 1 | 1999 | 41706 | 0.000 |
Why?
|